FORT WORTH, Texas--(BUSINESS WIRE)--April 25, 2005--Alcon, Inc., (NYSE:ACL) announced the launch of the AcrySof(R) ReSTOR(R) Intraocular Lens (IOL) at a press conference during the American Society of ...

FORT WORTH, Texas — Alcon’s ReStor multifocal IOL showed no difference in contrast sensitivity results from monofocal lenses, according to results of a multicenter trial. Almost 75% of patients ...

US Food and Drug Administration (FDA) grants approval of the AcrySof ® IQ ReSTOR ® +2.5 Diopter (D) Intraocular Lens (IOL) for sale in the US Expands Alcon`s IOL portfolio for the correction of near, ...

To estimate the lifetime cost consequences for society and the National Health Service (NHS) of bilateral monofocal (SI40NB) or multifocal (ReSTOR or Array-SA40) intraocular lense (IOL) implantation ...

Implanting the same presbyopia-correcting IOL technology in both eyes of a patient creates a “summation effect” that allows the lens to function more effectively than if different technologies are ...

A revolutionary advance in cataract surgery was introduced to this region by Glenn N. Pomerance, M.D. at Pomerance Eye Center, P.C., his office said. The Alcon AcrySof® ReSTOR® IOL is the first and ...

SALT LAKE CITY, UT--(Marketwired - Jun 14, 2017) - In March 2017, the U.S. Food and Drug Administration approved a new, advanced intraocular lens implant (IOL) called the Acrysof IQ ReSTOR® +2.5 ...

Basel, March 23, 2017 - Alcon, the global leader in eye care and a division of Novartis, has received approval from the US Food and Drug Administration (FDA) for its AcrySof® IQ ReSTOR® +2.5 ...

In a near-unanimous vote, a US Food and Drug Administration (FDA) device panel endorsed Alcon Research, Ltd's AcrySof IQ ReSTOR multifocal toric posterior chamber intraocular lens (IOL). The proposed ...

Basel, Switzerland, April 16, 2015-Alcon, the global leader in eye care and a division of Novartis, has received approval from the US Food and Drug Administration (FDA) for its AcrySof ® IQ ReSTOR ® ...